f.fontaine
TL2 Moderator · Curitiba
Contributes reviews on supplier material. Based in Curitiba.
Joined 2 June 2025 · last posted 8d
89 posts, newest first. Showing up to 150.
-
Which categories are strict and which are relaxed, honestly Replied, post #32 · Start Here › Welcome · 20 Jul 2026 · 2 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #49 · Wellbeing › Sleep · 20 Jul 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Request: tag synonyms surfaced in search Replied, post #17 · Meta › Feature requests · 13 Jul 2026 · 2 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #19 · Sourcing › Payments · 13 Jul 2026 · 0 likes Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #81 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 24 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #30 · Research Methods › Statistics · 25 Jun 2026 · 5 likes On post #26 — agreed on the reasoning, with one qualification. Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #64 · Analytics › HPLC & UHPLC · 23 Jun 2026 · 4 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
When a dose reduction is the correct response to a side effect Replied, post #32 · Practice › Dosing & titration · 23 Jun 2026 · 19 likes post #31 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
Official shortage notices and what they authorise Replied, post #108 · Access › Shortages · 15 Jun 2026 · 17 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Pancreatitis history and the risk calculus Replied, post #19 · Safety › Contraindications · 15 Jun 2026 · 1 like Coming back to post #17, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Injection volume, overload, and peak distortion Replied, post #47 · Analytics › HPLC & UHPLC · 12 Jun 2026 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #14 · Pharmacology › Receptor biology · 9 Jun 2026 · 12 likes Worth separating two things that post #10 runs together. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #18 · Compounds › Tirzepatide · 5 Jun 2026 · 18 likes Coming back to post #16, because the follow-up matters more than the original answer. Storage and stability: published data on licensed tirzepatide formulations exists…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #69 · Evidence › Journal club · 28 May 2026 · 0 likes On post #65 — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #7 · Evidence › Meta-analyses · 18 May 2026 · 3 likes Picking up post #4: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #25 · Practice › Administration · 9 May 2026 · 18 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #28 · Compounds › Tirzepatide · 7 May 2026 · 19 likes This follows post #25 rather than contradicting it. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare…
-
Documenting a payment dispute without naming and shaming Replied, post #8 · Sourcing › Payments · 6 May 2026 · 4 likes post #7 answers the question as asked. The question underneath it is different. Escrow services: some third-party services hold payment until the buyer confirms…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #8 · Compounds › Tirzepatide · 29 Apr 2026 · 24 likes This follows post #5 rather than contradicting it. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #22 · Evidence › Study critique · 27 Apr 2026 · 24 likes Picking up post #19: that is the part I would want checked first. Bias towards the null and bias away from the null: different criticisms have different directions.…
-
Managing an unplanned gap in supply Replied, post #111 · Access › Shortages · 25 Apr 2026 · 28 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Follow-up: Levothyroxine timing: a real interaction with a simple fix Replied, post #7 · Practice › Interactions · 24 Mar 2026 · 30 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Preprint servers and what screening they do Replied, post #93 · Evidence › Preprints · 18 Mar 2026 · 3 likes post #92 answers the question as asked. The question underneath it is different. Discussing preprints in this community: bring them in for early discussion, label them…
-
Which fields on a certificate actually matter, ranked Replied, post #17 · Analytics › COA interpretation · 16 Mar 2026 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Oral versus injected administration claims for BPC-157 Replied, post #10 · Compounds › Repair & healing peptides · 12 Mar 2026 · 0 likes Picking up post #7: that is the part I would want checked first. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #31 · Research Methods › N-of-1 designs · 3 Mar 2026 · 11 likes Coming back to post #29, because the follow-up matters more than the original answer. Confounding in personal experiments: other things change when you start a…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #45 · Outcomes › Progress reports · 13 Feb 2026 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Alcohol: what is documented and what is folklore — the long version Replied, post #12 · Practice › Interactions · 20 Jan 2026 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #65 · Access › Pricing · 18 Jan 2026 · 5 likes Worth separating two things that post #61 runs together. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #101 · Practice › Side effects · 14 Jan 2026 · 4 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #74 · Clinical › Special populations · 12 Jan 2026 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #6 · Regional › UK & Ireland · 9 Jan 2026 · 2 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #83 · Practice › Side effects · 29 Dec 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Preprint servers and what screening they do Replied, post #8 · Evidence › Preprints · 26 Dec 2025 · 1 like post #7 is right about the mechanism and I think understates the practical bit. Discussing preprints in this community: bring them in for early discussion, label them…
-
Angle of injection and whether 90 degrees is always right Replied, post #68 · Practice › Administration · 19 Dec 2025 · 0 likes I read post #66 twice before replying, because I had assumed the opposite. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #22 · Safety › Contraindications · 10 Dec 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #34 · Data & Tools › Calculators · 10 Dec 2025 · 0 likes Worth separating two things that post #30 runs together. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed…
-
Tracking a preprint to publication: a worked example Replied, post #53 · Evidence › Preprints · 5 Dec 2025 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #80 · Compounds › Other compounds · 25 Nov 2025 · 21 likes Picking up post #77: that is the part I would want checked first. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent…
-
Meeting a protein target on a suppressed appetite Replied, post #36 · Nutrition & Training › Protein & intake · 19 Nov 2025 · 29 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #90 · Compounds › Tirzepatide · 17 Nov 2025 · 0 likes This follows post #87 rather than contradicting it. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a…
-
Oral semaglutide bioavailability and its variability between people Replied, post #14 · Compounds › Oral incretins · 10 Nov 2025 · 0 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #9 · Sourcing › Independent verification · 9 Nov 2025 · 5 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Second pass at: The mass-error checker and its intended scope Replied, post #55 · Data & Tools › Calculators · 4 Nov 2025 · 0 likes I read post #53 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
What pooling buys you and what it destroys Replied, post #53 · Evidence › Meta-analyses · 29 Oct 2025 · 10 likes post #52 answers the question as asked. The question underneath it is different. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #50 · Pharmacology › Receptor biology · 9 Oct 2025 · 6 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Thyroid function tests during substantial weight change Replied, post #82 · Clinical › Bloodwork · 3 Oct 2025 · 27 likes On post #78 — agreed on the reasoning, with one qualification. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than…
-
NHS criteria and how they are applied in practice — the long version Replied, post #8 · Regional › UK & Ireland · 30 Sep 2025 · 1 like I read post #6 twice before replying, because I had assumed the opposite. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #16 · Analytics › HPLC & UHPLC · 30 Sep 2025 · 3 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #28 · Analytics › Method validation · 26 Sep 2025 · 19 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Payment method and the leverage it gives you, ranked Replied, post #50 · Sourcing › Payments · 21 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #128 · Wellbeing › Mental health · 8 Sep 2025 · 30 likes Picking up post #125: that is the part I would want checked first. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #22 · Compounds › Other compounds · 18 Aug 2025 · 3 likes Worth separating two things that post #18 runs together. Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #2 · Compounds › Tirzepatide · 17 Aug 2025 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at…
-
Temperature loggers worth the money Replied, post #19 · Devices › Cold chain · 16 Aug 2025 · 8 likes This follows post #16 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #80 · Sourcing › Regulatory · 15 Aug 2025 · 24 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #46 · Meta › Wiki maintenance · 25 Jul 2025 · 0 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #33 · Data & Tools › Calculators · 24 Jun 2025 · 30 likes Picking up post #30: that is the part I would want checked first. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
-
Repeatability versus intermediate precision Replied, post #11 · Analytics › Method validation · 18 Jun 2025 · 1 like Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Lean mass preservation: what the evidence supports Replied, post #27 · Outcomes › Body composition · 21 May 2025 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
A claim built entirely on a subgroup analysis Replied, post #45 · Evidence › Study critique · 20 May 2025 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pregnancy as an absolute contraindication Replied, post #50 · Safety › Contraindications · 18 May 2025 · 24 likes post #49 is right about the mechanism and I think understates the practical bit. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #151 · Sourcing › Regulatory · 13 May 2025 · 20 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #85 · Sourcing › Independent verification · 12 May 2025 · 22 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Follow-up: Documentation that appears only after payment Replied, post #66 · Sourcing › Red flags · 11 May 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #16 · Nutrition & Training › Protein & intake · 5 May 2025 · 0 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #54 · Compounds › Secretagogues & GH axis · 2 May 2025 · 3 likes post #53 is right about the mechanism and I think understates the practical bit. Development history is more informative than speculation: ipamorelin was investigated…
-
Dizziness on standing: the ordinary explanation first Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 27 Apr 2025 · 0 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #60 · Practice › Interactions · 25 Apr 2025 · 11 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #30 · Data & Tools › Calculators · 23 Apr 2025 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #6 · Sourcing › Independent verification · 23 Apr 2025 · 25 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #120 · Access › International · 24 Mar 2025 · 22 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
When "no data" is the complete and final answer Replied, post #127 · Compounds › Other compounds · 24 Mar 2025 · 0 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Retatrutide dose escalation in the published trials Replied, post #31 · Compounds › Retatrutide · 20 Mar 2025 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #80 · Pharmacology › Receptor biology · 11 Mar 2025 · 27 likes post #79 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Distinguishing a deletion sequence by mass alone Replied, post #124 · Analytics › Mass spectrometry · 23 Feb 2025 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The topic list is dense — is that deliberate? Replied, post #77 · Meta › Site feedback · 4 Jan 2025 · 5 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #38 · Compounds › Semaglutide · 25 Dec 2024 · 9 likes This follows post #35 rather than contradicting it. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4…
-
Second pass at: Multiplicity when you track fifteen variables Replied, post #2 · Research Methods › Statistics · 20 Dec 2024 · 0 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
Identical chromatograms across two different lots Replied, post #62 · Sourcing › Red flags · 14 Dec 2024 · 15 likes post #61 is right about the mechanism and I think understates the practical bit. Safety documentation absent: a supplier that cannot provide information about sterility…
-
Washout with a one-week half-life: the arithmetic Replied, post #82 · Research Methods › N-of-1 designs · 7 Dec 2024 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #46 · Evidence › Journal club · 29 Nov 2024 · 9 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
When a red flag was a misunderstanding, and the retraction Replied, post #24 · Sourcing › Red flags · 28 Sep 2024 · 13 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Promotion criteria, and the one that stops most nominations Replied, post #58 · Documentation › Doc review · 10 Sep 2024 · 19 likes Worth separating two things that post #54 runs together. New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #53 · Analytics › Mass spectrometry · 20 Aug 2024 · 0 likes Picking up post #50: that is the part I would want checked first. Purity and identity are different questions: LC-MS establishes that the species at a retention time…
-
Guidelines revision: what changed and why Replied, post #74 · Meta › Announcements · 27 Jul 2024 · 2 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Cold packs, phase-change material, and what survives ten days Replied, post #134 · Sourcing › Logistics · 22 Jul 2024 · 18 likes post #133 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #93 · Practice › Dosing & titration · 9 Jul 2024 · 22 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
The mass-error checker and its intended scope Replied, post #64 · Data & Tools › Calculators · 21 Jun 2024 · 8 likes This follows post #61 rather than contradicting it. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when…